HoneyNaps actively supplies “AI solutions” to U.S. medical institutions
Rapid commercialization and delivery to the U.S. after FDA approval Aiming to achieve a 10% market share within three years Aggressive sales and expansion of distribution network through U.S. subsidiaries BOSTON, Oct. 7, 2024… Read More »HoneyNaps actively supplies “AI solutions” to U.S. medical institutions